Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;20(12):2513-7.
doi: 10.1681/ASN.2009050497. Epub 2009 Sep 24.

The von Hippel Lindau tumor suppressor limits longevity

Affiliations

The von Hippel Lindau tumor suppressor limits longevity

Roman-Ulrich Müller et al. J Am Soc Nephrol. 2009 Dec.

Abstract

Many genes are responsible for the modulation of lifespan in model organisms. In addition to regulating adaptive biologic responses that control stress signaling and longevity, some of these genes participate in tumor formation. The mechanisms that determine longevity and link regulation of lifespan with tumorigenesis are poorly understood. Here, we show that the tumor suppressor von Hippel-Lindau (VHL), which has widely known roles in renal carcinogenesis and the formation of kidney cysts, controls longevity in Caenorhabditis elegans. Loss of vhl-1 significantly increased lifespan and resulted in accelerated basal signaling of the p38 mitogen-activated protein kinase PMK-3. Furthermore, the VHL-1 effect on the regulation of lifespan was independent of the insulin/IGF-1-like signaling pathway, suggesting a mechanism for stress resistance that controls both lifespan and tumorigenesis. These findings define VHL-1 as a player in longevity signaling and connect aging, regulation of lifespan, and stress responses with formation of renal cell carcinomas.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Loss of vhl-1 increases longevity. (A) Worms lacking vhl-1 (▲) show an extended lifespan as compared with the wild-type N2 strain (■). (B) RNAi-mediated knockdown of vhl-1 using two different RNAi constructs from either the Ahringer (#1) or the Vidal (#2) library confirms the VHL-1 effect on lifespan observed in vhl-1 knockout worms. (C) Lifespan extension mediated by VHL-1 does not depend on insulin/IRS-1–like signaling. Wild-type N2 (squares) or vhl-1 −/− worms (triangles) were grown on RNAi plates for downregulation of either daf-16/FOXO (blue line), simulating increased insulin signaling, or daf-2/insulin receptor (red line), which reduces insulin signaling.
Figure 2.
Figure 2.
Loss of vhl-1 is without effect on nuclear translocation of DAF-16. Activity of DAF-16 is dependent on its subcellular localization, because DAF-16 exerts its effects only in the nucleus. (A through C) In contrast to animals grown on bacteria expressing empty vector (A), knockdown of daf-2 leads to strong nuclear translocation of DAF-16 (B), whereas knockdown of vhl-1 is without effect (C).
Figure 3.
Figure 3.
Loss of vhl-1 is associated with enhanced PMK-3/p38 MAPK signaling. Phosphorylation of p38 (A, right) and JNK (B, right) MAPKs was assessed using phosphospecific antibodies on Western blots of whole lysates of control versus both vhl-1–deficient and hif-1;vhl-1 double-knockout worms. Equal total amounts of the two MAPKs independent of their phosphorylation status was determined using p38 (A, left) and JNK (B, left) antibodies on blots with the identical lysates.

References

    1. Kaelin WG, Jr: The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin Cancer Res 10: 6290S–6295S, 2004 - PubMed
    1. Iliopoulos O, Kibel A, Gray S, Kaelin WG, Jr: Tumour suppression by the human von Hippel-Lindau gene product. Nat Med 1: 822–826, 1995 - PubMed
    1. Schoenfeld A, Davidowitz EJ, Burk RD: A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. Proc Natl Acad Sci U S A 95: 8817–8822, 1998 - PMC - PubMed
    1. Kaelin WG, Jr: The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. J Am Soc Nephrol 14: 2703–2711, 2003 - PubMed
    1. Mandriota SJ, Turner KJ, Davies DR, Murray PG, Morgan NV, Sowter HM, Wykoff CC, Maher ER, Harris AL, Ratcliffe PJ, Maxwell PH: HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 1: 459–468, 2002 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources